Proteomics of Plasmodium vivax malaria: new insights, progress and potential

References

• Gupta H, Dhunputh P, Bhatt AN, et al. Cerebral malaria in a man with Plasmodium vivax mono-infection: a case report. Trop Doct. 2016;0049475515624857. [Epub ahead of print]
   Google Scholar
• Rahimi BA, Thakkinstian A, White NJ, et al. Severe vivax malaria: a systematic review and meta-analysis of clinical studies since 1900. Malar J. 2014;13:481. .
   PubMed Web of Science ®Google Scholar
• Nadkar MY, Huchche AM, Singh R, et al. Clinical profile of severe Plasmodium vivax malaria in a tertiary care centre in Mumbai from June 2010-January 2011. J Assoc Physicians India. 2012;60:11–13.
   PubMedGoogle Scholar
• WHO. World Malaria Report, 2015 [Internet]. Available from: http://apps.who.int/iris/bitstream/10665/200018/1/9789241565158_eng.pdf?ua=1.
   Google Scholar
• Carlton JM, Adams JH, Silva JC, et al. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature. 2008;455(7214):757–763. .
   PubMed Web of Science ®Google Scholar
• Miller LH, Mason SJ, Clyde DF, et al. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med. 1976;295(6):302–304.
   PubMed Web of Science ®Google Scholar
• Mendes C, Dias F, Figueiredo J, et al. Duffy negative antigen is no longer a barrier to Plasmodium vivax–molecular evidences from the African West Coast (Angola and Equatorial Guinea). PLoS Negl Trop Dis. 2011;5(6):e1192.
   PubMedGoogle Scholar
• Ngassa Mbenda HG, Das A. Molecular evidence of Plasmodium vivax mono and mixed malaria parasite infections in Duffy-negative native Cameroonians. PloS One. 2014;9(8):e103262.
   PubMedGoogle Scholar
• Mueller I, Galinski MR, Baird JK, et al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis. 2009;9(9):555–566. .
   PubMed Web of Science ®Google Scholar
• Bernabeu M, Lopez FJ, Ferrer M, et al. Functional analysis of Plasmodium vivax VIR proteins reveals different subcellular localizations and cytoadherence to the ICAM-1 endothelial receptor. Cell Microbiol. 2012;14(3):386–400.
   PubMed Web of Science ®Google Scholar
• Marín-Menéndez A, Bardají A, Martínez-Espinosa FE, et al. Rosetting in Plasmodium vivax: a cytoadhesion phenotype associated with anaemia. PLoS Negl Trop Dis. 2013;7(4):e2155.
   PubMed Web of Science ®Google Scholar
• Baird JK. Neglect of Plasmodium vivax malaria. Trends Parasitol. 2007;23(11):533–539.
   PubMed Web of Science ®Google Scholar
• Florens L, Washburn MP, Raine JD, et al. A proteomic view of the Plasmodium falciparum life cycle. Nature. 2002;419(6906):520–526.
   PubMed Web of Science ®Google Scholar
• Roch KGL, Johnson JR, Florens L, et al. Global analysis of transcript and protein levels across the Plasmodium falciparum life cycle. Genome Res. 2004;14(11):2308–2318.
   PubMed Web of Science ®Google Scholar
• Oehring SC, Woodcroft BJ, Moes S, et al. Organellar proteomics reveals hundreds of novel nuclear proteins in the malaria parasite Plasmodium falciparum. Genome Biol. 2012;13(11):R108.
   PubMedGoogle Scholar
• Reamtong O, Srimuang K, Saralamba N, et al. Protein profiling of mefloquine resistant Plasmodium falciparum using mass spectrometry-based proteomics. Int J Mass Spectrom. 2015;391:82–92.
   PubMed Web of Science ®Google Scholar
• Cobbold SA, Santos JM, Ochoa A, et al. Proteome-wide analysis reveals widespread lysine acetylation of major protein complexes in the malaria parasite. Sci Rep. 2016;6:19722.
   PubMedGoogle Scholar
• Ray S, Kamath KS, Srivastava R, et al. Serum proteome analysis of vivax malaria: an insight into the disease pathogenesis and host immune response. J Proteomics. 2012;75(10):3063–3080. .
   PubMed Web of Science ®Google Scholar
• Bachmann J, Burté F, Pramana S, et al. Affinity proteomics reveals elevated muscle proteins in plasma of children with cerebral malaria. PLoS Pathog. 2014;10(4):e1004038.
   PubMed Web of Science ®Google Scholar
• Swearingen KE, Lindner SE, Shi L, et al. Interrogating the plasmodium sporozoite surface: identification of surface-exposed proteins and demonstration of glycosylation on CSP and TRAP by mass spectrometry-based proteomics. PLoS Pathog [Internet]. 2016;12(4). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4851412/.
   PubMed Web of Science ®Google Scholar
• Mata-Cantero L, Azkargorta M, Aillet F, et al. New insights into host-parasite ubiquitin proteome dynamics in P. falciparum infected red blood cells using a TUBEs-MS approach. J Proteomics. 2016;139:45–59.
   PubMed Web of Science ®Google Scholar
• Mallela AR, Hariprasad S, Koya R, et al. Spontaneous subdural haemorrhage: a rare association with Plasmodium Vivax malaria. J Clin Diagn Res JCDR. 2016;10(1):OD05–OD06.
   PubMed Web of Science ®Google Scholar
• Lacerda MVG, Fragoso SCP, Alecrim MGC, et al. Postmortem characterization of patients with clinical diagnosis of Plasmodium vivax malaria: to what extent does this parasite kill? Clin Infect Dis. 2012;55(8):e67–e74.
   PubMed Web of Science ®Google Scholar
• Antony HA, Parija SC. Antimalarial drug resistance: an overview. Trop Parasitol. 2016;6(1):30–41.
   PubMedGoogle Scholar
• Rieckmann KH, Davis DR, Hutton DC. Plasmodium vivax resistance to chloroquine? Lancet Lond Engl. 1989;2(8673):1183–1184.
   PubMed Web of Science ®Google Scholar
• Baird JK, Basri H, Purnomo, et al. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Am J Trop Med Hyg. 1991; 44(5):547–552. .
   PubMed Web of Science ®Google Scholar
• Baird JK. Chloroquine resistance in Plasmodium vivax. Antimicrob Agents Chemother. 2004;48(11):4075–4083. .
   PubMed Web of Science ®Google Scholar
• Nomura T, Carlton JM, Baird JK, et al. Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. J Infect Dis. 2001;183(11):1653–1661.
   PubMed Web of Science ®Google Scholar
• Beeson JG, Chu CS, Richards JS, et al. Plasmodium vivax malaria: challenges in diagnosis, treatment and elimination. Pediatr Infect Dis J. 2015;34(5):529–531. .
   PubMed Web of Science ®Google Scholar
• Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits. Malar J [Internet]. 2014;13:418. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4230503/.
   PubMed Web of Science ®Google Scholar
• Collins WE, Jeffery GM. Primaquine resistance in Plasmodium vivax. Am J Trop Med Hyg. 1996;55(3):243–249.
   PubMed Web of Science ®Google Scholar
• Baird JK. Point-of-care G6PD diagnostics for Plasmodium vivax malaria is a clinical and public health urgency. BMC Med. 2015;13:296.
   PubMedGoogle Scholar
• Zakeri S, Motmaen SR, Afsharpad M, et al. Molecular characterization of antifolates resistance-associated genes, (dhfr and dhps) in Plasmodium vivax isolates from the Middle East. Malar J. 2009;8:20.
   PubMedGoogle Scholar
• Young MD, Burgess RW. Pyrimethamine resistance in Plasmodium vivax malaria. Bull World Health Organ. 1959;20(1):27–36.
   PubMedGoogle Scholar
• Hawkins VN, Joshi H, Rungsihirunrat K, et al. Antifolates can have a role in the treatment of Plasmodium vivax. Trends Parasitol. 2007;23(5):213–222.
   PubMed Web of Science ®Google Scholar
• Douglas NM, Anstey NM, Angus BJ, et al. Artemisinin combination therapy for vivax malaria? Lancet Infect Dis. 2010;10(6):405–416.
   PubMed Web of Science ®Google Scholar
• Harijanto PN. Malaria treatment by using artemisinin in Indonesia. Acta Medica Indones. 2010;42(1):51–56.
   PubMedGoogle Scholar
• Nelwan EJ, Ekawati LL, Tjahjono B, et al. Randomized trial of primaquine hypnozoitocidal efficacy when administered with artemisinin-combined blood schizontocides for radical cure of Plasmodium vivax in Indonesia. BMC Med. 2015;13:294.
   PubMedGoogle Scholar
• Gardner MJ, Hall N, Fung E, et al. Genome sequence of the human malaria parasite Plasmodium falciparum. Nature. 2002;419(6906):498–511.
   PubMed Web of Science ®Google Scholar
• Luo Z, Sullivan SA, Carlton JM. The biology of Plasmodium vivax explored through genomics. Ann N Y Acad Sci. 2015;1342:53–61.
   PubMed Web of Science ®Google Scholar
• Delgado-Ratto C, Gamboa D, Soto-Calle VE, et al. Population genetics of Plasmodium vivax in the peruvian Amazon. PLoS Negl Trop Dis. 2016;10(1):e0004376.
   Google Scholar
• Barry AE, Waltmann A, Koepfli C, et al. Uncovering the transmission dynamics of Plasmodium vivax using population genetics. Pathog Glob Health. 2015;109(3):142–152.
   PubMed Web of Science ®Google Scholar
• Flannery EL, Wang T, Akbari A, et al. Next-generation sequencing of plasmodium vivax patient samples shows evidence of direct evolution in drug-resistance genes. ACS Infect Dis. 2015;1(8):367–379.
   PubMed Web of Science ®Google Scholar
• Jang JW, Yun SG, Woo M-K, et al. Sequence polymorphisms of Plasmodium vivax tryptophan and alanine rich antigen (PvTARAg55). Acta Trop. 2015;142:122–126.
   PubMed Web of Science ®Google Scholar
• Chenet SM, Tapia LL, Escalante AA, et al. Genetic diversity and population structure of genes encoding vaccine candidate antigens of Plasmodium vivax. Malar J. 2012;11:68.
   PubMed Web of Science ®Google Scholar
• Bozdech Z, Mok S, Hu G, et al. The transcriptome of Plasmodium vivax reveals divergence and diversity of transcriptional regulation in malaria parasites. Proc Natl Acad Sci USA. 2008;105(42):16290–16295.
   PubMed Web of Science ®Google Scholar
• Westenberger SJ, McClean CM, Chattopadhyay R, et al. A systems-based analysis of Plasmodium vivax lifecycle transcription from human to mosquito. PLoS Negl Trop Dis. 2010;4(4):e653.
   PubMedGoogle Scholar
• Sims PF, Hyde JE. Proteomics of the human malaria parasite Plasmodium falciparum. Expert Rev Proteomics. 2006;3(1):87–95.
   PubMed Web of Science ®Google Scholar
• Ray S, Reddy PJ, Jain R, et al. Proteomic technologies for the identification of disease biomarkers in serum: advances and challenges ahead. Proteomics. 2011;11(11):2139–2161. .
   PubMed Web of Science ®Google Scholar
• Ray S, Patel SK, Kumar V, et al. Differential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures. Proteomics Clin Appl. 2014;8(1–2):53–72.
   PubMed Web of Science ®Google Scholar
• Burté F, Brown BJ, Orimadegun AE, et al. Severe childhood malaria syndromes defined by plasma proteome profiles. PLoS One. 2012;7(12):e49778.
   PubMed Web of Science ®Google Scholar
• Gitau EN, Kokwaro GO, Karanja H, et al. Plasma and cerebrospinal proteomes from children with cerebral malaria differ from those of children with other encephalopathies. J Infect Dis. 2013;208(9):1494–1503.
   PubMed Web of Science ®Google Scholar
• Kassa FA, Shio MT, Bellemare M-J, et al. New inflammation-related biomarkers during malaria infection. PLoS One. 2011;6(10):e26495.
   PubMed Web of Science ®Google Scholar
• Ray S, Kumar V, Bhave A, et al. Proteomic analysis of Plasmodium falciparum induced alterations in humans from different endemic regions of India to decipher malaria pathogenesis and identify surrogate markers of severity. J. Proteomics. 2015;127(Pt A):103–113.
   PubMedGoogle Scholar
• Andrade BB, Reis-Filho A, Souza-Neto SM, et al. Plasma superoxide dismutase-1 as a surrogate marker of vivax malaria severity. PLoS Negl Trop Dis. 2010;4(4):e650.
   PubMedGoogle Scholar
• Bahk YY, Na B-K, Cho S-H, et al. Proteomic analysis of haptoglobin and amyloid A protein levels in patients with vivax malaria. Korean J Parasitol. 2010;48(3):203–211.
   PubMed Web of Science ®Google Scholar
• Ray S, Renu D, Srivastava R, et al. Proteomic investigation of falciparum and vivax malaria for identification of surrogate protein markers. PLoS One. 2012;7(8):e41751.
   PubMedGoogle Scholar
• Ray S, Patel SK, Venkatesh A, et al. Clinicopathological analysis and multipronged quantitative proteomics reveal oxidative stress and cytoskeletal proteins as possible markers for severe vivax malaria. Sci Rep. 2016;6:24557. .
   PubMedGoogle Scholar
• Panichakul T, Ponnikorn S, Roytrakul S, et al. Plasmodium vivax inhibits erythroid cell growth through altered phosphorylation of the cytoskeletal protein ezrin. Malar J. 2015;14:138.
   PubMedGoogle Scholar
• Lasonder E, Ishihama Y, Andersen JS, et al. Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature. 2002;419(6906):537–542.
   PubMed Web of Science ®Google Scholar
• Udomsangpetch R, Somsri S, Panichakul T, et al. Short-term in vitro culture of field isolates of Plasmodium vivax using umbilical cord blood. Parasitol Int. 2007;56(1):65–69. .
   PubMed Web of Science ®Google Scholar
• Acharya P, Pallavi R, Chandran S, et al. A glimpse into the clinical proteome of human malaria parasites Plasmodium falciparum and Plasmodium vivax. Proteomics Clin Appl. 2009;3(11):1314–1325. .
   PubMed Web of Science ®Google Scholar
• Acharya P, Pallavi R, Chandran S, et al. clinical proteomics of the neglected human malarial parasite Plasmodium vivax. PLoS One [Internet]. 2011;6(10). Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3197670/. .
   Web of Science ®Google Scholar
• Roobsoong W, Roytrakul S, Sattabongkot J, et al. Determination of the Plasmodium vivax schizont stage proteome. J Proteomics. 1701–1710;74(9):2011. .
   Google Scholar
• Galinski MR, Barnwell JW. Non-human primate model for human malaria research. In: Nonhuman primates in biomedical research. Boston (MA): Academic Press; 2012. p. 299–323.
   Google Scholar
• Langhorne J, Buffet P, Galinski M, et al. The relevance of non-human primate and rodent malaria models for humans. Malar J. 2011;10:23.
   PubMed Web of Science ®Google Scholar
• Craig AG, Grau GE, Janse C, et al.. The role of animal models for research on severe malaria. PLoS Pathog [Internet]. 2012;8(2):e1002401. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271056/.
   PubMed Web of Science ®Google Scholar
• Moreno-Pérez DA, Dégano R, Ibarrola N, et al. Determining the Plasmodium vivax VCG-1 strain blood stage proteome. J Proteomics. 2014;113C:268–280. .
   PubMedGoogle Scholar
• Anderson DC, Lapp SA, Akinyi S, et al. Plasmodium vivax trophozoite-stage proteomes. J Proteomics. 2015;115:157–176. .
   PubMed Web of Science ®Google Scholar
• Lu F, Li J, Wang B, et al. Profiling the humoral immune responses to Plasmodium vivax infection and identification of candidate immunogenic rhoptry-associated membrane antigen (RAMA). J Proteomics. 2014;102:66–82. .
   PubMed Web of Science ®Google Scholar
• Chen J-H, Chen S-B, Wang Y, et al. An immunomics approach for the analysis of natural antibody responses to Plasmodium vivax infection. Mol Biosyst. 2015;11(8):2354–2363. .
   PubMed Web of Science ®Google Scholar
• Baum E, Sattabongkot J, Sirichaisinthop J, et al. Submicroscopic and asymptomatic Plasmodium falciparum and Plasmodium vivax infections are common in western Thailand - molecular and serological evidence. Malar J. 2015;14:95. .
   PubMed Web of Science ®Google Scholar
• Snounou G, Viriyakosol S, Jarra W, et al. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol. 1993;58(2):283–292.
   PubMed Web of Science ®Google Scholar
• Shanks GD. Control and elimination of Plasmodium vivax. Adv Parasitol. 2012;80:301–341.
   PubMed Web of Science ®Google Scholar
• Tsuboi T, Takeo S, Arumugam TU, et al. The wheat germ cell-free protein synthesis system: a key tool for novel malaria vaccine candidate discovery. Acta Trop. 2010;114(3):171–176. .
   PubMed Web of Science ®Google Scholar
• Arévalo-Herrera M, Lopez-Perez M, Dotsey E, et al. Antibody profiling in Naïve and semi-immune individuals experimentally challenged with Plasmodium vivax sporozoites. PLoS Negl Trop Dis. 2016;10(3):e0004563. .
   PubMed Web of Science ®Google Scholar
• Molina DM, Finney OC, Arevalo-Herrera M, et al. Plasmodium vivax pre-erythrocytic–stage antigen discovery: exploiting naturally acquired humoral responses. Am J Trop Med Hyg. 2012;87(3):460–469. .
   PubMed Web of Science ®Google Scholar
• Genton B, D’Acremont V, Rare L, et al. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 2008;5(6):e127.
   PubMed Web of Science ®Google Scholar
• Price RN, Tjitra E, Guerra CA, et al. Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2007;77:79–87.
   PubMed Web of Science ®Google Scholar